BioChaperone Lispro versus faster aspart and insulin aspart in patients with type 1 diabetes using continuous subcutaneous insulin infusion: A randomized euglycemic clamp study

Pharmacological properties of faster-acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: A randomized, double-blind, crossover trial

(2016) Tim Heise et al.   DIABETES OBESITY & METABOLISM

Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics

(2015) Paolo Pozzilli et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Comparison of the pharmacokinetic and pharmacodynamic profiles of insulin degludec and insulin glargine

(2015) Tim Heise et al.   Expert Opinion on Drug Metabolism & Toxicology

Patch Pump Versus Conventional Pump: Postprandial Glycemic Excursions and the Influence of Wear Time

(2013) Yoeri M. Luijf et al.   Diabetes Technology & Therapeutics

Effect of Insulin Catheter Wear-Time on Subcutaneous Adipose Tissue Blood Flow and Insulin Absorption in Humans

(2009) Trine Schnedler Clausen et al.   Diabetes Technology & Therapeutics

Effect of Age of Infusion Site and Type of Rapid-Acting Analog on Pharmacodynamic Parameters of Insulin Boluses in Youth With Type 1 Diabetes Receiving Insulin Pump Therapy

(2008) K. L. Swan et al.   DIABETES CARE

Severe hypoglycaemia and glycaemic control in Type1 diabetes: meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion

(2008) J. C. Pickup et al.   DIABETIC MEDICINE